KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Ionis Pharmaceuticals (IONS) over the last 13 years, with Q4 2024 value amounting to $3.8 million.

  • Ionis Pharmaceuticals' Treasury Shares rose 1827.72% to $3.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.8 million, marking a year-over-year increase of 1827.72%. This contributed to the annual value of $3.8 million for FY2024, which is 1827.72% up from last year.
  • According to the latest figures from Q4 2024, Ionis Pharmaceuticals' Treasury Shares is $3.8 million, which was up 1827.72% from $3.2 million recorded in Q4 2023.
  • Ionis Pharmaceuticals' Treasury Shares' 5-year high stood at $3.8 million during Q4 2024, with a 5-year trough of $1.5 million in Q1 2020.
  • Moreover, its 5-year median value for Treasury Shares was $2.7 million (2021), whereas its average is $2.7 million.
  • In the last 5 years, Ionis Pharmaceuticals' Treasury Shares soared by 34373.83% in 2020 and then surged by 565.32% in 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' Treasury Shares (Quarter) stood at $2.4 million in 2020, then grew by 10.28% to $2.6 million in 2021, then rose by 5.65% to $2.8 million in 2022, then grew by 17.1% to $3.2 million in 2023, then grew by 18.28% to $3.8 million in 2024.
  • Its Treasury Shares was $3.8 million in Q4 2024, compared to $3.2 million in Q4 2023 and $2.8 million in Q4 2022.